Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 15,923 | 18,979 | 11,727 | 7,010 | 8,479 |
| Operating Income | -15,923 | -18,979 | -11,727 | -7,010 | -8,479 |
| Other Income | 234 | 221 | 164 | 126 | 119 |
| Pre-tax Income | -15,689 | -18,758 | -11,563 | -6,884 | -8,360 |
| Net Income Continuous | -15,689 | -18,758 | -11,563 | -6,884 | -8,360 |
| Net Income | $-15,689 | $-18,758 | $-11,563 | $-6,884 | $-8,360 |
| EPS Basic Total Ops | -0.33 | -1.15 | -0.23 | -0.14 | -0.18 |
| EPS Basic Continuous Ops | -0.27 | -0.32 | -0.23 | -0.14 | -0.18 |
| EPS Diluted Total Ops | -0.33 | -1.15 | -0.23 | -0.14 | -0.18 |
| EPS Diluted Continuous Ops | -0.27 | -0.32 | -0.23 | -0.14 | -0.18 |
| EBITDA(a) | $-15,638 | $-18,900 | $-11,456 | $-6,741 | $-8,171 |